The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ESSO 43 | Balancing innovation and outcomes in cancer surgery: insights on robotic techniques and patient care
Isabel Rubio, MD, PhD, Vall d’Hebron University Hospital, Barcelona, Spain, discusses the dual focus of cancer surgeons on innovative techniques that enhance patients’ quality of life while ensuring these methods demonstrate equivalent or improved oncologic outcomes. In a session on robotic surgery for various cancers, including breast, pancreas, and thyroid, she emphasizes the feasibility and comparable complication rates to traditional open techniques. However, Dr Rubio points out that definitive oncological outcomes are still awaited, as local recurrences may take years to manifest. She also stresses the importance of evaluating cost-effectiveness to ensure optimal patient care, highlighting the critical responsibility of cancer surgeons. This interview took place at the ESSO 43 congress in Antwerp, Belgium.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
